Dr. Wirginia Krzyściak | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award
Acting Head of Department of Medical Diagnostics at the Faculty of Pharmacy of the Medical College of the Jagiellonian University in Krakow, Poland
Dr. Wirginia Krzyściak is a distinguished researcher and academic leader in the field of medical diagnostics, currently serving as the Acting Head of the Department of Medical Diagnostics at the Jagiellonian University Medical College (JU MC) in Poland. With a career spanning over a decade, she has made significant contributions to the study of schizophrenia, clinical biochemistry, and the relationship between oral microbiota and brain function 🧠. A prolific author with 85 original scientific papers and a strong h-index of 16, Dr. Krzyściak’s work is highly regarded in both national and international academic circles 🌍. She also serves on the editorial boards of several high-impact scientific journals, focusing on biostatistics, brain diseases, and biomolecules related to biofilm diseases. Beyond her research, she is actively involved in mentoring, having supervised numerous master’s and doctoral theses 🎓.
Professional profile
Education📚
Professional Experience🏛️
Dr. Wirginia Krzyściak has over a decade of professional experience in the fields of medical diagnostics and clinical biochemistry. Since 2010, she has held various academic positions at Jagiellonian University Medical College (JU MC), starting as an Assistant and later becoming an Adjunct in the Department of Medical Diagnostics 🧑🔬. She is currently the Acting Head of the Department, where she leads cutting-edge research on schizophrenia and biomolecular diagnostics. Beyond her academic role, Dr. Krzyściak is an expert consultant for the Central Medical Laboratory in Bytom 🏥. Her leadership extends to numerous research projects, including those focused on oral microbiota and brain function. Dr. Krzyściak is also deeply involved in mentoring, having supervised 25 master’s theses and two doctoral dissertations 🎓. Her comprehensive experience in research, diagnostics, and teaching makes her a key figure in the field of clinical biochemistry and pharmaceutical sciences.
Research Interest🌐
Awards and Honors🏆
Publications top noted📜
- From Periphery Immunity to Central Domain Through Clinical Interview as a New Insight on Schizophrenia
Krzyściak, W., Szwajca, M., Śmierciak, N., Skalniak, A., Popiela, T.
Scientific Reports (2024), 14(1), 5755
🔬 Citations: 1 - Association of Blood Metabolomics Biomarkers with Brain Metabolites and Patient-Reported Outcomes as a New Approach in Individualized Diagnosis of Schizophrenia
Krzyściak, W., Bystrowska, B., Karcz, P., Popiela, T., Pilecki, M.
International Journal of Molecular Sciences (2024), 25(4), 2294
🧠 Citations: 0 - Modified Lactoperoxidase System as a Promising Anticaries Agent: In Vitro Studies on Streptococcus mutans Biofilms
Magacz, M., Alatorre-Santamaría, S., Kędziora, K., Pamuła, E., Krzyściak, W.
International Journal of Molecular Sciences (2023), 24(15), 12136
🦷 Citations: 1 - Benefits and Meaning of Lipids Profile in Relation to Oxidative Balance and Brain Morphology in Schizophrenia
Śmierciak, N., Krzyściak, W., Szwajca, M., Aleksandrovych, V., Pilecki, M.
International Journal of Molecular Sciences (2023), 24(14), 11375
🧬 Citations: 3 - The Association of the Oral Microbiota with the Effects of Acid Stress Induced by an Increase of Brain Lactate in Schizophrenia Patients
Krzyściak, W., Karcz, P., Bystrowska, B., Popiela, T.J., Pilecki, M.
Biomedicines (2023), 11(2), 240
🧫 Citations: 4 - Safety Assessment of the Modified Lactoperoxidase System—In Vitro Studies on Human Gingival Fibroblasts
Magacz, M., Papież, M., Kościelniak, D., Pamuła, E., Krzyściak, W.
International Journal of Molecular Sciences (2023), 24(3), 2640
🧪 Citations: 2 - Risk Factors for Weight Gain in Patients with First-Episode Psychosis
Batko, B., Szwajca, M., Śmierciak, N., Turek, A., Pilecki, M.
Psychiatria Polska (2023), 57(1), pp. 51–64
🏋️ Citations: 1 - Immunological Routine Laboratory Parameters at Admission Influence the Improvement of Positive Symptoms in Schizophrenia Patients After Pharmacological Treatment
Skalniak, A., Krzyściak, W., Śmierciak, N., Kozicz, T., Pilecki, M.
Frontiers in Psychiatry (2023), 14, 1082135
💊 Citations: 4 - Effect of a Short-Term Intervention with Lactobacillus salivarius Probiotic on Early Childhood Caries—An Open Label Randomized Controlled Trial
Staszczyk, M., Jamka-Kasprzyk, M., Kościelniak, D., Krzyściak, W., Jurczak, A.
International Journal of Environmental Research and Public Health (2022), 19(19), 12447
👶 Citations: 11